The International League of Associations for Rheumatology issues an annual request for proposals for projects that advance rheumatology in developing countries.
The 2017 application period is closed. (Applications for proposals for the 2018 calendar year were accepted July 3 – September 15, 2017).
In 2017, ILAR welcomed project proposals for ILAR’s contribution to projects between the amounts of $5,000 and $25,000 U.S. dollars. ILAR will fund up to $130,000 for projects in 2018.
Leagues of rheumatology associations, national rheumatology societies, universities and academic institutions, government agencies and individuals from institutions are all eligible to submit a proposal for consideration. Project proposals must clearly demonstrate that they address ILAR’s mission to advance rheumatology in developing countries in the areas of patient education, health professional education, including population health* and clinical practice, and advocacy for rheumatology. ILAR’s focus is specifically to advance the education and clinical practice of rheumatology in the developing world and therefore submitted proposals should demonstrate how they will impact improvements in education population health* and/or the clinical practice of rheumatology.
ILAR will not fund research projects.
*Population Health is defined as health outcomes of a group of individuals including the distribution of such outcomes within the group.
In 2017, ILAR will give special consideration to these prioritized areas:
- Advocacy for Rheumatology through disease awareness campaigns. ILAR will fund up to $5,000 each for projects that address public awareness campaigns for rheumatology. An example includes translating EULAR’s “Don’t Delay, Connect Today” campaign into various languages to be shared in your community.
- Guidelines for emerging diseases (e.g., recognition and treatment of Chikungunya). ILAR recognizes that infectious agents and environmental events may have prolonged and untoward musculoskeletal effects.
- Modify current treatment recommendations for major rheumatic diseases to include practical solutions when only limited resources are available. ILAR recognizes that current treatment guidelines are not possible in some underdeveloped countries and could be modified based on best practices in those countries.
- COPCORD Registry ILAR is committed to funding at least one new COPCORD registry site in a developing country.
Award Terms and Funding
In 2017 ILAR solicited proposals for projects that clearly demonstrate that they address ILAR’s mission to advance rheumatology in developing countries in the areas of education, population health* and/or clinical practice for the funding year January 1 – December 31, 2018. In total, ILAR will fund up to $130,000 U.S. dollars for projects in 2018. Special consideration will be given to projects involving multiple leagues. ILAR’s intent in funding these projects is to provide seed money to help initiate meritorious projects that would eventually be eligible for other sources of funding.
Details about the 2018 application process will be provided before submissions open.
Conditions of Award
*You will only be required to complete this form if your project is selected for funding.
The Conditions of Award document outlines the payment schedule and terms of the award, and requires a signature from the awardee. This signed original document must be returned to ILAR by the due date indicating formal acceptance of the award. The first payment is scheduled for February of the award year; however no funds will be released prior to the receipt of this document.
To make sure the projects stay on task, ILAR will withhold 10% of the award until a six-month progress report is submitted. You are also expected to submit a manuscript to be considered for publication in ILAR’s journal Clinical Rheumatology. Details and instructions on how to submit a manuscript to Clinical Rheumatology will be included with your letter of agreement.
For more information, please contact ILAR at email@example.com or 404-633-3777.